SiDx developed a near-bedside blood-typing platform that simultaneously detects blood antigens and antibodies in a multiplexed test, supporting rapid, type-specific transfusions in emergency care
SiDx developed a near-bedside blood-typing platform that simultaneously detects blood antigens and antibodies in a multiplexed test, supporting rapid, type-specific transfusions in emergency care. The company is reported to have shut down.